Jeffrey N. Weitzel, MD is Chief of the Division of Clinical Cancer Genomics and the Cancer Screening & Prevention Program at the City of Hope Comprehensive Cancer Center in Duarte, California. Dr. Weitzel is Board Certified in clinical genetics and medical oncology, and he is a Professor of Oncology and Population Sciences at the City of Hope. He is the inaugural holder of Dr. Norman and Melinda Payson Professorship in Medical Oncology.
At the vanguard of precision medicine, Dr. Weitzel’s multidisciplinary clinical, research, and training programs emphasize translational research in genomic cancer risk assessment, chemoprevention, targeted therapy, clinical and psychosocial outcomes, genetic epidemiology and health services research in underserved minorities and in Latin America. He is a member of the American Society of Clinical Oncology, the American Association for Cancer Research, the American Society of Human Genetics and the NCCN Genetics/Familial Risk Assessment practice guidelines committee. Dr. Weitzel is the principal investigator for the City of Hope Clinical Cancer Genomics Community Research Network and Medical Director for the Cancer Genomics Education Program, which is funded in part by the National Cancer Institute.